Skip to main content
Log in

The use of risperidone long-acting injection (RLAI) does not reduce the number of days spent in hospital

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Taylor D, Fischetti C, Sparshatt A, Thomas A, Bishara D, Cornelius V.Risperidone long-acting injection: a 6-year mirror-image study of healthcare resource use. Acta Psychiatrica Scandinavica 120: 97-101, No. 2, Aug 2009

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The use of risperidone long-acting injection (RLAI) does not reduce the number of days spent in hospital. Pharmacoecon. Outcomes News 588, 9 (2009). https://doi.org/10.2165/00151234-200905880-00024

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905880-00024

Keywords

Navigation